** FOR CREDENTIALED MEDIA ONLY **
As part of the FDA and CDC’s commitment to transparency, we invite you to join us for a virtual press conference through Zoom. This press conference will be live streamed at the FDA’s the YouTubeexternal icon course
We will ask you to participate in the Zoom virtual press conference with a camera so that speakers can see you as you ask questions. Reporters who ask questions will show the screen to the speakers and the public. Your image will also be broadcast via YouTube’s live stream on YouTube.
A joint virtual press conference with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.
- Janet Woodcock, MD, Acting FDA Commissioner
- Rochelle Walensky, MD, CDC Director
- Peter Marks, MD, Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
- Anne Schuchat, MD, Chief Deputy Director of the CDC
KANUS-A: Friday, April. 23, 7:15 pm ET
DIIN: Registration is required to participate in the press conference – REGISTERexternal icon
Registration is limited to media credentials and pre -registration is required at this link:
** The confirmation email contains an internal link to join the press conference via Zoom. **
For questions about the virtual press conference, please contact the FDA’s Office of Media Affairs at: email@example.com.